Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Handheld Optical Device Screens for Early Necrotizing Enterocolitis in Preterm Infants

By HospiMedica International staff writers
Posted on 18 Jun 2026

Necrotizing enterocolitis (NEC) is a sudden, rapidly progressive intestinal disease of premature infants that can lead to sepsis, surgery, and death. More...

Clinicians struggle to recognize NEC at its earliest stages before damage becomes visible on imaging. Early identification could enable timely medical therapy and reduce operative risk. To help address this challenge, investigators have developed a noninvasive optical device to screen preterm infants for early signs of NEC.

Broadband optical spectroscopy (BOS) was developed at Ann & Robert H. Lurie Children’s Hospital of Chicago in collaboration with a biomedical engineering laboratory at Northwestern University. The handheld device is designed for bedside use in the neonatal intensive care unit. The first-in-human study reporting its clinical use has been published in the Journal of Pediatric Surgery. The technology aims to detect NEC earlier than radiography can.

The BOS probe is placed gently on the infant’s abdomen. It measures infrared light reflected from the intestines and analyzes spectral signatures for changes in color that surgeons recognize as indicative of threatened intestinal tissue in NEC. The assessment is completed within about two minutes and does not expose infants to pain or radiation.

In the initial clinical evaluation, investigators tested BOS in 96 premature infants who were younger than 36 weeks’ gestation. Infants with congenital cardiac conditions or abdominal wall defects were excluded. The study found that BOS was safe and feasible in this population and produced detectable signal changes in infants with NEC. The findings support further validation of BOS as a screening modality to identify earlier stages of disease, when antibiotic therapy may still be effective.

“Our results show that BOS is a safe and feasible technology that produced detectable signal changes in premature infants with NEC. These findings suggest that BOS is a promising and potentially groundbreaking modality for screening and early detection of NEC,” said Seth Goldstein, MD, MPhil, pediatric general and thoracic surgeon at Lurie Children’s and Associate Professor of Surgery at Northwestern University Feinberg School of Medicine.

Related Links
Ann & Robert H. Lurie Children’s Hospital of Chicago
Northwestern University Feinberg School of Medicine


Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Hypodermic Syringe
SurTract™ Safety Syringe
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image:The NCIBT team with the cath lab members celebrating the completion of the study. (Image Credit: UC Davis)

Dual-Imaging Catheter Completes Initial Human Evaluation of Coronary Plaque

Atherosclerosis involves plaque buildup in arterial walls that can narrow blood vessels and increase the risk of heart attack, stroke, and other serious cardiovascular conditions. In coronary arteries,... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.